Manufacturer of Controlled Substances; Notice of Application; AMPAC Fine Chemicals, LLC, 60145 [2012-24189]
Download as PDF
<![CDATA[
60145
Federal Register / Vol. 77, No. 191 / Tuesday, October 2, 2012 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
Sigma Aldrich Research Biochemicals,
Inc.
Pursuant to 1301.33(a), Title 21 of the
Code of Federal Regulations (CFR), this
is notice that on August 2, 2012, Sigma
Aldrich Research Biochemicals, Inc., 1–
3 Strathmore Road, Natick,
Massachusetts 01760–2447, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Schedule
4-Methyl-2,5dimethoxyamphetamine (7395).
Dimethyltryptamine (7435) ...........
I
I
Dated: September 20, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
AMPAC Fine Chemicals, LLC
wreier-aviles on DSK5TPTVN1PROD with NOTICES
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances ISP, Inc.; Notice of
Registration
By Notice dated June 18, 2012, and
published in the Federal Register on
June 26, 2012, 77 FR 38087, ISP, Inc.,
238 South Main Street, Assonet,
Massachusetts 02702, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Schedule
2,5-Dimethoxyamphetamine
(7396).
Amphetamine (1100) ....................
Phenylacetone (8501) ..................
BILLING CODE 4410–09–P
Pursuant to 1301.33(a), Title 21 of the
Code of Federal Regulations (CFR), this
is notice that on July 10, 2012, AMPAC
Fine Chemicals, LLC., Highway 50 and
Hazel Avenue, Building 05001, Rancho
Cordova, California 95670, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Tapentadol (9780), a basic class of
Jkt 229001
BILLING CODE 4410–09–P
Drug
[FR Doc. 2012–24186 Filed 10–1–12; 8:45 am]
15:04 Oct 01, 2012
Dated: September 20, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–24189 Filed 10–1–12; 8:45 am]
The company plans to manufacture
reference standards.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than December 3, 2012.
VerDate Mar<15>2010
controlled substance listed in schedule
II.
The company plans to manufacture
the listed controlled substance for
distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substance,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than December 3, 2012.
I
II
II
The company plans to manufacture
bulk API, for distribution to its
customers. The bulk 2,5Dimethoxyamphetamine will be used
for conversion into non-controlled
substances.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of ISP,
Inc., to manufacture the listed basic
classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated ISP,
Inc., to ensure that the company’s
registration is consistent with the public
interest.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: September 25, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–24193 Filed 10–1–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Apertus Pharmaceuticals, LLC
By Notice dated June 4, 2012, and
published in the Federal Register on
June 12, 2012, 77 FR 35058, Apertus
Pharmaceuticals, LLC., 331 Consort
Drive, St Louis, Missouri 63011, made
application to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Drug
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
Schedule
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
for distribution to their customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Apertus Pharmaceuticals, LLC., to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time.
DEA has investigated Apertus
Pharmaceuticals, LLC., to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
E:\FR\FM\02OCN1.SGM
02OCN1
]]>Agencies
[Federal Register Volume 77, Number 191 (Tuesday, October 2, 2012)]
[Notices]
[Page 60145]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24189]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
AMPAC Fine Chemicals, LLC
Pursuant to 1301.33(a), Title 21 of the Code of Federal Regulations
(CFR), this is notice that on July 10, 2012, AMPAC Fine Chemicals,
LLC., Highway 50 and Hazel Avenue, Building 05001, Rancho Cordova,
California 95670, made application by letter to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of
Tapentadol (9780), a basic class of controlled substance listed in
schedule II.
The company plans to manufacture the listed controlled substance
for distribution to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substance, may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than December 3, 2012.
Dated: September 20, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-24189 Filed 10-1-12; 8:45 am]
BILLING CODE 4410-09-P
